GRI-001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGRI-001
Drug Alias Namenatural killer cell type I inhibitor (Glycoregimmune)natural killer cell type I inhibitor (GRI Bio)GRI-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNatural killer T-lymphocyte inhibitors
TargetsUpdating
Therapy Area/IndicationsFatty Liver, Alcoholic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGri Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGri Bio Inc
Active IndicationsN/A
Inactive IndicationsFatty Liver, Alcoholic

Other Information

ATC CodeN/A
Related LinksN/A